Posted by Michael Wonder on 12 Sep 2022
EMA publishes agenda for 12-15 September 2022 CHMP meeting
12 September 2022 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Nirsevimab
- Sutimlimab
- Maribavir
- Gozetotide
- Melatonin
- Octreotide acetate
- Mitapivat sulphate
- Sorafenib tosylate
- Teriflunomide
- Teriparatide
- Loncastuximab tesirine
